Successful treatment of cutaneous and subcutaneous zygomycosis in an immunosuppressed patient with aplastic anaemia

Journal of Paediatrics and Child Health

Volumn 43, Issue 1-2, 2007, Pages 87-89

  Chan, Yumin ^a   Goldwater, Paul ^a,b   Saxon, Ben ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Immunosuppression; Neutropenia; Zygomycosis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; MEROPENEM; METHYLPREDNISOLONE; POSACONAZOLE; RIFAMPICIN; THYMOCYTE ANTIBODY; TIMENTIN; VANCOMYCIN;

APLASTIC ANEMIA; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CANDIDA ALBICANS; CASE REPORT; DEBRIDEMENT; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROSCOPY; MUCORMYCOSIS; NEUTROPENIA; PRIORITY JOURNAL; RECTUS FEMORIS MUSCLE; RHIZOPUS ORYZAE; SCHOOL CHILD; SWELLING; TENSOR FASCIA LATA MUSCLE;

ANEMIA, APLASTIC; CHILD; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; SOUTH AUSTRALIA; TREATMENT OUTCOME; ZYGOMYCOSIS;

EID: 33845809492     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2007.01010.x     Document Type: Article

References (10)

1. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation and management. Clin. Microbiol. Rev. 2005; 18: 556-69.
2. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review on the clinical manifestations, diagnosis and treatment. Clin. Microbiol. Infect 2004; 10 (Suppl. 1): 31-47.
3. Roden MM, Zaoutis TE, Buchanan WL et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin. Infect Dis. 2005; 41: 634-53.
4. Ellis DH. Systemic zygomycosis. In: Merz WG, Hay RJ, eds. Medical Mycology: Topley and Wilson's Microbiology and Microbial Infections, 10th edn. London: Hodder Arnold, 2005; 659-86.
5. Sugar AM. Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Bennett and Dolin's Principles and Practice of Infectious Diseases, 6th edn. Philadelphia: Elsevier Churchill Livingstone, 2005; 2973-84.
6. Gonzalez CE, Rinaldi MG, Sugar AM. Zygomycosis. Infect. Dis. Clin. North Am. 2002; 16: 895-914.
7. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin. Microbiol. Rev. 2000; 13: 236-301.
8. Torres HA, Hachem. RY, Chemaly RF et al. Posaconazole: a broad spectrum triazole antifungal. Lancet Infect. Dis. 2005; 5: 775-85.
9. Sahin B, Paydas S, Cosar E et al. Role of GCSF in treatment of mucormycosis. Eur. J. Clin. Microbiol. Infect. Dis 1996; 15: 866-88.
10. Gonzalez CE, Couriel DR, Walsh TJ. Disseminated zygomycosis in a neutropenic patient: successful treatment with Amphotericin B lipid complex and GCSF. Clin. Infect. Dis. 1997; 24: 192-6.